Rhodium(I) and Silver(I) Complexes of 4, 5‐Dicyano‐1, 3‐dimesityl‐ and 4, 5‐Dicyano‐1, 3‐dineopentylimidazol‐2‐ylidene

The new N‐heterocyclic carbene (NHC) precursors 4, ‐dicyano‐1, ‐dimesityl‐ ( 9 ) and 4, 5‐dicyano‐1, 3‐dineopentyl‐2‐(pentafluorophenyl)imidazoline ( 14 ) were synthesized. The structure of 9 could be determined by X‐ray crystallography. With the 2‐pentafluorophenyl‐substituted imidazolines 9 and 14 , the [AgCl(NHC)], [RhCl(COD)(NHC)], and [RhCl(CO)₂(NHC)] complexes [NHC = 4, 5‐dicyano‐1, 3‐dimesitylimidazol‐2‐ylidene ( 3 ) and 4, 5‐dicyano‐1, 3‐dineopentylimidazol‐2‐ylidene ( 4 )] were obtained. Crystal structures of [AgCl( 3 )] ( 15 ), [RhCl(COD)( 3 )] ( 17 ), [RhCl(COD)( 4 )] ( 18 ), and [RhCl(CO)₂( 3 )] ( 19 ) were solved and with the crystal data of 19 , the percent buried volume ( %V_bur) of 31.8(±0.1) % was determined for NHC 3 . Infrared spectra of the imidazolines 9 and 14 and of the complexes 15 – 20 were recorded and the CO stretching frequencies of complexes 19 and 20 were used to determine the Tolman electronic parameters of the newly obtained NHCs 3 (TEP: 2060 cm^–1) and 4 (TEP: 2061 cm^–1), thus proving that 1, 3‐substitution of maleonitrile‐NHCs does not have a significant effect for the high π‐acceptor strength of these carbenes.     

[N,N′‐Bis(2,6‐diisopropylphenyl)acenaphthene‐1,2‐diimine‐1κ2N,N′]heptacarbonyl‐1κC,2κ3C,3κ3C‐di‐μ3‐tellurido‐triiiron(II)(2 Fe—Fe)

The sterically hindered title complex, [Fe₃Te₂(C₃₆H₄₀N₂)(CO)₇], was obtained by substitution of two carbonyl groups in the [Fe₃(μ₃‐Te)₂(CO)₉] cluster by the bulky redox‐active N,N′‐bis(2,6‐diisopropylphenyl)acenaphthene‐1,2‐diimine (dpp‐BIAN) ligand. The asymmetric unit contains two molecules of the same geometry. The C=N bond lengths in dpp‐BIAN indicate a rather low level of electron transfer from the cluster core to the dpp‐BIAN ligand.     

Redox Reaction of the Pd0 Complex Bearing the Trost Ligand with meso‐Cycloalkene‐1,4‐biscarbonates Leading to a Diamidato PdII Complex and 1,3‐Cycloalkadienes: Enantioselective Desymmetrization Versus Catalyst Deactivation

The Pd⁰ complex 1 that bears the Trost ligand 2 undergoes a facile redox reaction with 1,4‐biscarbonates 5 b – d and rac‐ 22 under formation of the diamidato–Pd^II complex 7 and the corresponding 1,3‐cycloalkadienes 8 b – d . The redox deactivation of complex 1 was the dominating pathway in the reaction of 5 b – d with HCO₃^? at room temperature. However, at 0 °C the six‐membered biscarbonate 5 b , catalytic amounts of complex 1 , and HCO₃^? mainly reacted in an allylic alkylation, which led to a highly selective desymmetrization of the substrate and gave alcohol 6 b with ≥99 % ee in 66 % yield. An increase of the catalyst loading in the reaction of 5 b with 1 and HCO₃^? afforded the bicyclic carbonate 12 b (96 % ee, 92 %). Formation of carbonate 12 b involves two consecutive inter‐ and intramolecular substitution reactions of the π‐allyl–Pd^II complexes 16 b and 18 b , respectively, with O‐nucleophiles and presumably proceeds through the hydrogen carbonate 17 b as key intermediate. The intermediate formation of 17 b is also indicated by the conversion of alcohol rac‐ 6 b to carbonate 12 b upon treatment with HCO₃^? and 1 . The Pd⁰‐catalyzed desymmetrization of 5 b with formation of 12 b and its hydrolysis allow an efficient enantioselective synthesis of diol 13 b . The reaction of the seven‐membered biscarbonate 5 c with ent‐ 1 and HCO₃^? afforded carbonate ent‐ 12 c (99 % ee, 39 %). The Pd⁰ complex 1 is stable in solution and suffers no intramolecular redox reaction with formation of complex 7 and dihydrogen as recently claimed for the similar Pd⁰ complex 9 . Instead, complex 1 is rapidly oxidized by dioxygen to give the stable Pd^II complex 7 . Thus, formation of the Pd^II complex 10 from 9 was most likely due to an oxidation by dioxygen. Oxidative workup (air) of the reaction mixture stemming from the desymmetrization of 5 c catalyzed by 1 gave the Pd^II complex 7 in high yield besides carbonate 12 c .     

Synthese,Struktur und Reaktivität von η1und η3‐Allyl‐Rhenium‐Carbonylen

Synthesis, Structure, and Reactivity of η¹‐ and η³‐Allyl Rhenium Carbonyls In (η³‐C₃H₅)Re(CO)₄ one CO ligand can be substituted by PPh₃, pyridine, isocyanide and benzonitrile. With 1,2‐bis(diphenylphosphino)ethylene, 1,1′‐bis(diphenylphosphino)ferrocene and 1,2‐bis(4‐pyridyl)ethane dinuclear ligand bridged complexes are obtained. The η³‐η¹ conversion of the allyl ligand occurs on reaction of (η³‐C₃H₅)Re(CO)₄ with the bidendate ligands 1,2‐bis(diphenylphosphino)ethane and 1,3‐bis(diphenylphosphino)propane and with 2,2′‐bipyridine (L–L) which gives the complexes (η¹‐C₃H₅)Re(CO)₃(L–L). By reaction of (η³‐C₃H₅)Re(CO)₄ with bis(diphenylphosphino)methane the allyl group is protonated and under elemination of propene the complex (OC)₃Re(Ph₂PCHPPh₂)(η¹‐Ph₂PCH₂PPh₂) ( 19 ) with a diphosphinomethanide ligand is formed. On heating solutions of (η³‐C₃H₅)Re(CO)₄ and (η³‐C₃H₅)Re(CO)₃(CN‐2,5‐Me₂C₆H₃) ( 5 ) in methanol the methoxy bridged compounds Re₄(CO)₁₂(OH)(OMe)₃ and Re₂(CO)₄(CN‐2,5‐Me₂C₆H₃)₄(μ‐OMe)₂ ( 20 ) were isolated. The crystal structures of (η³‐C₃H₅)Re(CO)₃(CNCH₂SiMe₃) ( 4 ), [(η³‐C₃H₅)(OC)₃Re]₂‐ (μ‐bis‐(diphenylphosphino)ferrocene) ( 8 ), (η¹‐C₃H₅)Re(CO)₃‐ (bpy) ( 14 ), of 19 , 20 and of (OC)₃Re‐[Ph₂P(CH₂)₃PPh₂]Cl ( 16 ) were determined by X‐ray diffraction.     

Microwave‐Assisted Synthesis of Arylated Pyrrolo[2,1‐a]Isoquinoline Derivatives via Sequential [3 + 2] Cycloadditions and Suzuki‐Miyaura Cross‐Couplings in Aqueous Medium

Treatment of 5‐bromo‐2‐(bromoacetyl)thiophene ( 1 ) with isoquinoline gave the isoquinolinium bromide 2 . Reaction of 2 with acrylic acid derivatives, in the presence of MnO₂, afforded the 3‐[(5‐bromothiophen‐2‐ylcarbonyl]pyrrolo[2,1‐a]‐isoquinolines 3a , 3b . Suzuki–Miyaura cross‐coupling reactions of the bromides 3a , 3b in aqueous solvent with several activated and deactivated aryl(hetaryl)boronic acids 4a , 4b , 4c , 4d , 4e , 4f using a Pd(II)‐complex under thermal heating as well as microwave‐irradiating conditions afforded the corresponding new arylated pyrrolo[2,1‐a]isoquinoline derivatives 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 in high to excellent isolated yields.     

One‐pot Synthesis of 1,2,3,4‐Tetrahydropyrimidin‐2(1H)‐thione Derivatives and their Biological Activity

2‐Thioxo/oxo‐1,2,3,4‐tetrahydropyrimidine‐5‐carboxylate derivatives 2a , 2b , 2c , 2d were prepared by the reaction of ethyl acetoacetate and thiourea or urea with aldehydes using NH₄Cl as a catalyst. Compounds 2a and 2c reacted with mono and bihalogenated compounds such as ethyl iodide, chloroacetonitrile, epichlorohydrin, acetyl chloride, ethyl bromoacetate, chloroacetic acid, chloroacetylchloride, and/or oxalyl chloride to afford compounds 3 , 4a , 4b , 5 , 6a , 6b , 7 , 8 , 9 and 10 , respectively. Compounds 2a , 2c , and 7 were allowed to react with p‐fluorobenzaldehyde to yield the corresponding products 11a , 11b , and 12 , respectively. Oxidation of 2a and 2c gave 2b , 13a , 13b , 14 , 15 , 16 dependent on the oxidizing agent used. Vilsmeiere‐Haack formylation of 2a and 2b with POCl₃/DMF afforded 17a and 17b . Chlorination of 2b and 2d gave the chlorinated derivative 18a and 18b , which reacted with thiourea to give thioureidopyrimidine 19a and 19b . Reactions of 2a with hydrazine monohydrate, semicarbazide hydrochloride, and sodium hydroxide gave compounds 20 , 21 , 22 , respectively. The cytotoxicity and in vitro anticancer evaluation of some prepared compounds have been assessed against two different human tumor cell lines including breast adenocarcinoma MCF‐7 and human hepatocellular carcinoma HepG2. Antimicrobial and antioxidant activities of some compounds were investigated. The newly synthesized compounds were characterized by IR, ¹H‐NMR, ¹³C‐NMR, and mass spectral data.     

Synthesis of New Heterocyclic Compounds Using 2‐(3,3‐dimethyl‐1H‐pyrroloisoquinolin‐2(3H)‐ylidene)malonaldehydes

Isoquinolin‐5‐ylhydrazinium chloride 13 and 5‐bromoisoquinolin‐8‐ylhydrazinium chloride 14 were converted via Fischer syntheses with 3‐methylbutan‐2‐one into indolenines, 2,3,3‐trimethyl‐3H‐pyrrolo[2,3‐f]isoquinoline 15 and 5‐bromo‐2,3,3‐trimethyl‐3H‐pyrrolo[3,2‐h]isoquinoline 16 , respectively. Exposure of the indolenines to the Vilsmeier reagent produced diformyl compounds 17 and 18 , which reacted with arylhydrazines to give the corresponding pyrazoles 19a , 19b , 19c , 19d , 19e , 19f , 19g , 19h , 19i and 20a , 20b , 20c , 20d , 20e , 20f , 20g . Reaction of 17 with thiourea gave a pyrimidine‐2(1H)‐thione 23 or with hydroxylamine hydrochloride, an isoxazole 24 .     

Highly Active,Low‐Valence Molybdenum‐ and Tungsten‐Amide Catalysts for Bifunctional Imine‐Hydrogenation Reactions

The reactions of [M(NO)(CO)₄(ClAlCl₃)] (M=Mo, W) with (iPr₂PCH₂CH₂)₂NH, (PN^HP) at 90 °C afforded [M(NO)(CO)(PN^HP)Cl] complexes (M=Mo, 1a ; W, 1b ). The treatment of compound 1a with KOtBu as a base at room temperature yielded the alkoxide complex [Mo(NO)(CO)(PN^HP)(OtBu)] ( 2a ). In contrast, with the amide base Na[N(SiMe₃)₂], the PN^HP ligand moieties in compounds 1a and 1b could be deprotonated at room temperature, thereby inducing dehydrochlorination into amido complexes [M(NO)(CO)(PNP)] (M=Mo, 3a ; W, 3b ; PNP=(iPr₂PCH₂CH₂)₂N)). Compounds 3a and 3b have pseudo‐trigonal‐bipyramidal geometries, in which the amido nitrogen atom is in the equatorial plane. At room temperature, compounds 3a and 3b were capable of adding dihydrogen, with heterolytic splitting, thereby forming pairs of isomeric amine‐hydride complexes [Mo(NO)(CO)H(PN^HP)] ( 4a(cis) and 4a(trans) ) and [W(NO)(CO)H(PN^HP)] ( 4b(cis) and 4b(trans) ; cis and trans correspond to the position of the H and NO groups). H₂ approaches the Mo/W?N bond in compounds 3a , 3b from either the CO‐ligand side or from the NO‐ligand side. Compounds 4a(cis) and 4a(trans) were only found to be stable under a H₂ atmosphere and could not be isolated. At 140 °C and 60 bar H₂, compounds 3a and 3b catalyzed the hydrogenation of imines, thereby showing maximum turnover frequencies (TOFs) of 2912 and 1120 h^?1, respectively, for the hydrogenation of N‐(4 ‐ methoxybenzylidene)aniline. A Hammett plot for various para‐substituted imines revealed linear correlations with a negative slope of ?3.69 for para substitution on the benzylidene side and a positive slope of 0.68 for para substitution on the aniline side. Kinetics analysis revealed the initial rate of the hydrogenation reactions to be first order in c(cat.) and zeroth order in c(imine). Deuterium kinetic isotope effect (DKIE) experiments furnished a low k_H/k_D value (1.28), which supported a Noyori‐type metal–ligand bifunctional mechanism with H₂ addition as the rate‐limiting step.     

fac‐Bromo­tri­carbonyl­[2‐(2‐pyridylmethyl)‐2,3‐di­hydro‐1H‐isoindol‐1‐one]­rhenium(I) methanol solvate

The structure of the title compound, fac‐[ReBr(C₁₄H₁₂N₂O)(CO)₃]·CH₄O, consists of neutral mononuclear mol­ecular units of distorted octahedral geometry, with the three carbonyl donors in a facial orientation. The remaining coordination sites are occupied by the Br atom, the pyridine N atom and the ketone O‐atom donor of the ligand. The mol­ecules pack in stacks of antiparallel tapes, with a network of classical (O—H⋯Br) and non‐classical (C—H⋯O) hydrogen bonds between the methanol solvent mol­ecule and the complex mol­ecule.     

Reactions of Stable α‐Chlorosulfanyl Chlorides with CS‐Functionalized Compounds

The smooth reaction of 3‐chloro‐3‐(chlorosulfanyl)‐2,2,4,4‐tetramethylcyclobutanone ( 3 ) with 3,4,5‐trisubstituted 2,3‐dihydro‐1H‐imidazole‐2‐thiones 8 and 2‐thiouracil ( 10 ) in CH₂Cl₂/Et₃N at room temperature yielded the corresponding disulfanes 9 and 11 (Scheme 2), respectively, via a nucleophilic substitution of Cl^? of the sulfanyl chloride by the S‐atom of the heterocyclic thione. The analogous reaction of 3‐cyclohexyl‐2,3‐dihydro‐4,5‐diphenyl‐1H‐imidazole‐2‐thione ( 8b ) and 10 with the chlorodisulfanyl derivative 16 led to the corresponding trisulfanes 17 and 18 (Scheme 4), respectively. On the other hand, the reaction of 3 and 4,4‐dimethyl‐2‐phenyl‐1,3‐thiazole‐5(4H)‐thione ( 12 ) in CH₂Cl₂ gave only 4,4‐dimethyl‐2‐phenyl‐1,3‐thiazol‐5(4H)‐one ( 13 ) and the trithioorthoester derivative 14 , a bis‐disulfane, in low yield (Scheme 3). At ?78°, only bis(1‐chloro‐2,2,4,4‐tetramethyl‐3‐oxocyclobutyl)polysulfanes 15 were formed. Even at ?78°, a 1 : 2 mixture of 12 and 16 in CH₂Cl₂ reacted to give 13 and the symmetrical pentasulfane 19 in good yield (Scheme 5). The structures of 11, 14, 17 , and 18 have been established by X‐ray crystallography.     

Ferrocenyl,Alkyl, and Aryl‐Pyrido[2,3‐d]Pyrimidines as Vasorelaxant of Smooth Muscle of Rat Aorta via cAMP Conservation Through Phosphodiesterase Inhibition

New pyrido[2,3‐d]pyrimidines 11 , 12 , 13 , and 21 have been synthesized. The vasorelaxant effect on smooth muscle isolated from rat aorta, via PDEs inhibition, of these compounds along with other pyrido[2,3‐d]pyrimidines 14 , 15 , 16 , 17 , 18 , 19 , 20 reported earlier by our group, has also been determined. These pyrido[2,3‐d]pyrimidines 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 were synthesized by the reaction of ferrocenyl‐ethynyl ketones ( 1 , 2 , 3 , 4 ) or α‐alkynyl ketones ( 5 , 6 , 7 , 8 , 9 , 10 ) with 6‐amino‐1,3‐dimethyluracil using [Ni(CN)₄]^?4 as an active catalytic species, formed in situ in a Ni(CN)₂/NaOH/H₂O/CO/KCN aqueous system. Evaluation of the vasorelaxant effect of compounds 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 demonstrated that all compounds relax the tissue in a concentration‐dependent manner. The structural changes do not alter the effectiveness; however, there are differences related to potency expressed as EC₅₀. Compounds 12 (7‐ferrocenyl‐1,3‐dimethyl‐5‐(m‐tolyl)‐pyrido[2,3‐d]pyrimidine) and 13 (7‐ferrocenyl‐1,3‐dipropyl‐5‐(4‐metoxyphenyl)‐pyrido[2,3‐d]pyrimidine) were the most potent compounds, even more than rolipram, reference drug; the EC₅₀ was 0.41 ± 0.02 μM and 0.81 ± 0.11 μM for 12 and 13 , correspondingly. The EC₅₀ of compounds 15 (7‐ferrocenyl‐1,3‐dimethyl‐5‐phenyl‐pyrido[2,3‐d]pyrimidine), 14 (7‐ferrocenyl‐5‐(3,5‐dimethoxyphenyl)‐1,3‐dimethylpyrido[2,3‐d]pyrimidine), and 19 (5‐n‐butyl‐7‐ethyl‐1,3‐dimethylpyrido[2,3‐d]pyrimidine) was similar to EC₅₀ of rolipram. Compounds 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 significantly induce concentration‐dependent vasorelaxation in endothelium‐intact aortic rings. In addition, the relaxation responses to each compound in either endothelium‐intact or endothelium denuded aortic rings were comparable, suggesting that removal of the functional endothelium has no significant influence on its intrinsic vasorelaxant activity. In vitro capability of conserving cyclic‐AMP or cyclic‐GMP (adenosine and guanosine 3′, 5′‐cyclic monophosphate) via PDE inhibition for compounds 12 , 13 , 14 , 15 and 19 was evaluated. Compounds 15 and 19 show the highest percent inhibition effect (94.83% and 83.98%, respectively) for the decomposition of c‐AMP. Docking studies showed that the compound 15 was selective for the inhibition of PDE‐4.     

2,3‐Di(2‐pyridyl)‐5‐phenylpyrazine: A NN‐CNN‐Type Bridging Ligand for Dinuclear Transition‐Metal Complexes

A new bridging ligand, 2,3‐di(2‐pyridyl)‐5‐phenylpyrazine (dpppzH), has been synthesized. This ligand was designed so that it could bind two metals through a NN‐CNN‐type coordination mode. The reaction of dpppzH with cis‐[(bpy)₂RuCl₂] (bpy=2,2′‐bipyridine) affords monoruthenium complex [(bpy)₂Ru(dpppzH)]²⁺ ( 12+ ) in 64 % yield, in which dpppzH behaves as a NN bidentate ligand. The asymmetric biruthenium complex [(bpy)₂Ru(dpppz)Ru(Mebip)]³⁺ ( 23+ ) was prepared from complex 12+ and [(Mebip)RuCl₃] (Mebip=bis(N‐methylbenzimidazolyl)pyridine), in which one hydrogen atom on the phenyl ring of dpppzH is lost and the bridging ligand binds to the second ruthenium atom in a CNN tridentate fashion. In addition, the RuPt heterobimetallic complex [(bpy)₂Ru(dpppz)Pt(C?CPh)]²⁺ ( 42+ ) has been prepared from complex 12+ , in which the bridging ligand binds to the platinum atom through a CNN binding mode. The electronic properties of these complexes have been probed by using electrochemical and spectroscopic techniques and studied by theoretical calculations. Complex 12+ is emissive at room temperature, with an emission λ_max=695 nm. No emission was detected for complex 23+ at room temperature in MeCN, whereas complex 42+ displayed an emission at about 750 nm. The emission properties of these complexes are compared to those of previously reported Ru and RuPt bimetallic complexes with a related ligand, 2,3‐di(2‐pyridyl)‐5,6‐diphenylpyrazine.     

Hetaryl‐1,5 Benzodiazepines—Part I: Synthesis of 3‐pyrimidinyl‐ and Imidazolyl‐1,5‐benzodiazepines

Nucleophilic substitution of 3‐bromo‐4‐phenyl‐1H‐[1,5]benzodiazepin‐2‐one ( 1 ) with thiourea or guanidine in presence of potassium carbonate afforded 1,5‐benzodiazepin‐3‐ylimidothiocarbamate 2 or 1,5‐benzodiazepin‐3‐ylguanidine 3 , respectively. Pyrimidylthiobenzodiazepines 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 were obtained via the reaction of compound 2 with malononitrile dimer, diethyl malonate, methylenemalononitriles, or a mixture of an aldehyde and β‐keto esters or acetylacetone, catalyzed using ceric ammonium nitrate. Reaction of compound 2 or 3 with α‐halo esters, nitriles, and/or ketones afforded imidazoles 14 , 15 , 16 , 17 , 18 , 19 , 20 , respectively.     

In Situ FTIR and NMR Spectroscopic Investigations on Ruthenium‐Based Catalysts for Alkene Hydroformylation

Homogeneous ruthenium complexes modified by imidazole‐substituted monophosphines as catalysts for various highly efficient hydroformylation reactions were characterized by in situ IR spectroscopy under reaction conditions and NMR spectroscopy. A proper protocol for the preformation reaction from [Ru₃(CO)₁₂] is decisive to prevent the formation of inactive ligand‐modified polynuclear complexes. During catalysis, ligand‐modified mononuclear ruthenium(0) carbonyls were detected as resting states. Changes in the ligand structure have a crucial impact on the coordination behavior of the ligand and consequently on the catalytic performance. The substitution of CO by a nitrogen atom of the imidazolyl moiety in the ligand is not a general feature, but it takes place when structural prerequisites of the ligand are fulfilled.     

Dimethyl 2,2′‐bipyridine‐6,6′‐dicarboxylate and bis(dimethyl 2,2′‐bipyridine‐6,6′‐dicarboxylato‐κ2N,N′)copper(I) tetrafluoroborate

The single‐crystal X‐ray structures of dimethyl 2,2′‐bipyridine‐6,6′‐dicarboxylate, C₁₄H₁₂N₂O₄, and the copper(I) coordination complex bis(dimethyl 2,2′‐bipyridine‐6,6′‐dicarboxylato‐κ²N,N′)copper(I) tetrafluoroborate, [Cu(C₁₄H₁₂N₂O₄)₂]BF₄, are reported. The uncoordinated ligand crystallizes across an inversion centre and adopts the anticipated anti pyridyl arrangement with coplanar pyridyl rings. In contrast, upon coordination of copper(I), the ligand adopts an arrangement of pyridyl donors facilitating chelating metal coordination and an increased inter‐pyridyl twisting within each ligand. The distortion of each ligand contrasts with comparable copper(I) complexes of unfunctionalized 2,2′‐bipyridine.     

Reactive E=C(p‐p)π‐Systems. 55. [1] Ligand Properties of 1‐Trifluoromethyl‐2‐diethylamino‐2‐fluoro‐1‐arsaethene,F3CAs=C(F)NEt2

Due to the mesomeric interaction of the nitrogen lone pair with the As=C double bond, the perfluoroarsapropene derivative F₃CAs=C(F)NEt₂ ( 1 ) is sufficiently stable to serve as a ligand in transition metal carbonyl complexes. 1 was coordinated to chromium by reaction with the photochemically generated labile complex Cr(CO)₅(THF), yielding the monosubstituted pentacarbonyl derivative Cr(CO)₅[F₃CAs=C(F)NEt₂] ( 2 ). Already at room temperature, this is slowly transformed into the binuclear complex [F₃CAs=C(F)NEt₂][Cr(CO)₅]₂ ( 3 ) by replacing 1 from a neighbouring molecule by the stronger donor 2 . In a closed system 3 obviously exists in an equilibrium with 1 and 2 . Both complexes are related to the previously studied derivatives of the 2‐dimethylamino‐perfluoro‐1‐phosphapropene ligand. The products were identified by spectroscopic (IR, NMR) investigations and comparison with the related phosphaalkene complexes.     

PtII Complexes with 6‐(5‐Trifluoromethyl‐Pyrazol‐3‐yl)‐2,2′‐Bipyridine Terdentate Chelating Ligands: Synthesis,Characterization, and Luminescent Properties

A series of Pt^II complexes Pt(fpbpy)Cl ( 1 ), Pt(fpbpy)(OAc) ( 2 ), Pt(fpbpy)(NHCOMe) ( 3 ), Pt(fpbpy)(NHCOEt) ( 4 ), and [Pt(fpbpy)(NCMe)](BF₄) ( 5 ) with deprotonated 6‐(5‐trifluoromethyl‐pyrazol‐3‐yl)‐2,2′‐bipyridine terdentate ligand are prepared, among which 1 is converted to complexes 2 – 5 by a simple ligand substitution. Alternatively, acetamide complex 3 is prepared by hydrolysis of acetonitrile complex 5 , while the back conversion from 3 to 1 is regulated by the addition of HCl solution, showing the reaction sequence 1 → 5 → 3 → 1 . Multilayer OLED devices are successfully fabricated by using triphenyl‐(4‐(9‐phenyl‐9H‐fluoren‐9‐yl)phenyl) silane (TPSi‐F) as host material and with doping concentrations of 1 varying from 7 to 100 %. The electroluminescence showed a substantial red‐shifting versus the normal photoluminescence detected in solution. Moreover, at a doping concentration of 28 %, the device showed a saturated red luminescence with a maximum external quantum yield of 8.5 % at 20 mA cm^?2 and a peak luminescence of 47 543 cd m^?2 at 18.5 V.     

Preparation of 5‐methyl‐2‐sulfanyl‐7h‐1,3,4‐thiadiazolo[3,2‐a]‐pyrimidin‐7‐ones

7H‐1,3,4‐Thiadiazolo[3,2‐a]pyrimidin‐7‐ones can be prepared by the acylation of 5‐amino‐1,3,4‐thiadiazoles with diketene and subsequent ring closure (dehydration). Whereas arylthio substituents (SC₆H₅) can be introduced in 2‐position by the replacement of Br, alkylthio groups (SC₂H₅) have to be already presentin the starting 5‐amino‐1,3,4‐thiadiazole. The ambident nucleophile 2‐thiazolidinethione reacts in the Br substitution reaction on the N atom.     

[Fe2(μsb‐CO)(CO)3(NO)(μ‐PtBu2)(μ‐Ph2PCH2PPh2)]: Synthese,Kristallstruktur und Koordinationsisomerie

[Fe₂(μ_sb‐CO)(CO)₃(NO)(μ‐P^tBu₂)(μ‐Ph₂PCH₂PPh₂)]: Synthesis, X‐ray Crystal Structure and Isomerization Na[Fe₂(μ‐CO)(CO)₆(μ‐P^tBu₂)] ( 1 ) reacts with [NO][BF₄] at —60 °C in THF to the nitrosyl complex [Fe₂(CO)₆(NO)(μ‐P^tBu₂)] ( 2 ). The subsequent reaction of 2 with phosphanes (L) under mild conditions affords the complexes [Fe₂(CO)₅(NO)L(μ‐P^tBu₂)], L = PPh₃, ( 3a ); η‐dppm (dppm = Ph₂PCH₂PPh₂), ( 3b ). In this case the phosphane substitutes one carbonyl ligand at the iron tetracarbonyl fragment in 2 , which was confirmed by the X‐ray crystal structure analysis of 3a . In solution 3b loses one CO ligand very easily to give dppm as bridging ligand on the Fe‐Fe bond. The thus formed compound [Fe₂(CO)₄(NO)(μ‐P^tBu₂)(μ‐dppm)] ( 4 ) occurs in solution in different solvents and over a wide temperature range as a mixture of the two isomers [Fe₂(μ_sb‐CO)(CO)₃(NO)(μ‐P^tBu₂)(μ‐dppm)] ( 4a ) and [Fe₂(CO)₄(μ‐NO)(μ‐P^tBu₂)(μ‐dppm)] ( 4b ). 4a was unambiguously characterized by single‐crystal X‐ray structure analysis while 4b was confirmed both by NMR investigations in solution as well as by means of DFT calculations. Furthermore, the spontaneous reaction of [Fe₂(CO)₄(μ‐H)(μ‐P^tBu₂)(μ‐dppm)] ( 5 ) with NO at —60 °C in toluene yields a complicated mixture of products containing [Fe₂(μ‐CO)(CO)₄(μ‐H)(μ‐P^tBu₂)(μ‐dppm)] ( 6 ) as main product beside the isomers 4a and 4b occuring in very low yields.     

Synthesis of Tetrahydropyridoimidazole‐2‐acetates: Effect of Carboxy and Methoxycarbonyl Groups at C(2) on the Inhibition of Some β‐ and α‐Glycosidases

The gluco‐ and manno‐tetrahydropyridoimidazole‐2‐acetates and ‐acetic acids 16 and 17 , and 20 and 21 , respectively, were synthesized by condensation, in the presence of HgCl₂, of the known thionolactam 26 with the β‐amino ester 25 that was obtained by addition of AcOMe to the imine 22 , followed by debenzylation. The resulting methyl esters 16 and 20 were hydrolyzed to the acetic acids 17 and 21 . The (methoxycarbonyl)‐imidazole 14 and the acid 15 were obtained via the known aldehyde 29 . The imidazoles 14 – 17, 20 , and 21 were tested as inhibitors of the β‐glucosidase from Caldocellum saccharolyticum, the α‐glucosidase from brewer's yeast, the β‐mannosidase from snail, and the α‐mannosidase from Jack beans (Tables 1–3). There is a similar dependence of the K_i values on the nature of the C(2)‐substituent in the gluco‐ and manno‐series. With the exception of 19 , manno‐imidazoles are weaker inhibitors than the gluco‐analogues. The methyl acetates 16 and 20 are 3–4 times weaker than the methyl propionates 5 and 11 , in agreement with the hydrophobic effect. The gluco‐configured (methoxycarbonyl)‐imidazole 14 is 20 times weaker than the methyl acetate 16 , reflecting the reduced basicity of 14 , while the manno‐configured (methoxycarbonyl)‐imidazole 18 is only 1.2 times weaker than the methyl acetate 20 , suggesting a binding interaction of the MeOCO group and the β‐mannosidase. The carboxylic acids 6, 12, 15, 17, 19 , and 21 are weaker inhibitors than the esters, with the propionic acids 6 and 12 being the strongest and the carboxy‐imidazoles 15 and 19 the weakest inhibitors. The manno‐acetate 21 inhibits the β‐mannosidase ca. 8 times less strongly than the propionate 12 , but only 1.5 times more strongly than the carboxylate 19 , suggesting a compensating binding interaction also of the COOH group and the β‐mannosidase. The α/β selectivity for the gluco‐imidazoles ranges between 110 for 15 and 13.4?10³ for 6 ; the manno‐imidazoles are less selective. The methyl propionates proved the strongest inhibitors of the α‐glucosidase (IC₅₀ ( 5 )=25 μM ) and the α‐mannosidase (K_i( 11 ) =0.60 μM ).